Literature DB >> 10318867

Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein.

P Kaspar1, M Dvoráková, J Králová, P Pajer, Z Kozmik, M Dvorák.   

Abstract

Using the yeast two-hybrid system, the transcription factor ATBF1 was identified as v-Myb- and c-Myb-binding protein. Deletion mutagenesis revealed amino acids 2484-2520 in human ATBF1 and 279-300 in v-Myb as regions required for in vitro binding of both proteins. Further experiments identified leucines Leu325 and Leu332 of the Myb leucine zipper motif as additional amino acid residues important for efficient ATBF1-Myb interaction in vitro. In co-transfection experiments, the full-length ATBF1 was found to form in vivo complexes with v-Myb and inhibit v-Myb transcriptional activity. Both ATBF1 2484-2520 and Myb 279-300 regions were required for the inhibitory effect. Finally, the chicken ATBF1 was identified, showing high degree of amino acid sequence homology with human and murine proteins. Our data reveal Myb proteins as the first ATBF1 partners detected so far and identify amino acids 279-300 in v-Myb as a novel protein-protein interaction interface through which Myb transcriptional activity can be regulated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10318867     DOI: 10.1074/jbc.274.20.14422

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells.

Authors:  Xue-Yuan Dong; Peng Guo; Xiaodong Sun; Qunna Li; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

2.  Infrequent mutation of ATBF1 in human breast cancer.

Authors:  Xiaodong Sun; Yingfa Zhou; Kristen B Otto; Mingrong Wang; Ceshi Chen; Wei Zhou; Krithika Subramanian; Paula M Vertino; Jin-Tang Dong
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-24       Impact factor: 4.553

3.  Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP.

Authors:  Xue-Yuan Dong; Xiaoying Fu; Songqing Fan; Peng Guo; Dan Su; Jin-Tang Dong
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

4.  Targeting activation-induced cytidine deaminase overcomes tumor evasion of immunotherapy by CTLs.

Authors:  Jin-Qing Liu; Pramod S Joshi; Chuansong Wang; Hani Y El-Omrani; Yi Xiao; Xiuping Liu; John P Hagan; Chang-Gong Liu; Lai-Chu Wu; Xue-Feng Bai
Journal:  J Immunol       Date:  2010-04-19       Impact factor: 5.422

5.  Transcriptional repression by AtMYB4 controls production of UV-protecting sunscreens in Arabidopsis.

Authors:  H Jin; E Cominelli; P Bailey; A Parr; F Mehrtens; J Jones; C Tonelli; B Weisshaar; C Martin
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

6.  Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.

Authors:  Ines Schwering; Andreas Bräuninger; Verena Distler; Julia Jesdinsky; Volker Diehl; Martin-Leo Hansmann; Klaus Rajewsky; Ralf Küppers
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

7.  Patterns of CTCF and ZFHX3 Mutation and Associated Outcomes in Endometrial Cancer.

Authors:  Christopher J Walker; Mario A Miranda; Matthew J O'Hern; Joseph P McElroy; Kevin R Coombes; Ralf Bundschuh; David E Cohn; David G Mutch; Paul J Goodfellow
Journal:  J Natl Cancer Inst       Date:  2015-09-01       Impact factor: 13.506

8.  Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway.

Authors:  Antonio A Postigo
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

9.  Alteration of C-MYB DNA binding to cognate responsive elements in HL-60 variant cells.

Authors:  C Gaillard; E Le Rouzic; C Créminon; B Perbal
Journal:  Mol Pathol       Date:  2002-10

10.  Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer.

Authors:  Sylvie Desjardins; Joly Charles Beauparlant; Yvan Labrie; Geneviève Ouellette; Francine Durocher
Journal:  BMC Cancer       Date:  2009-06-12       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.